Innsbruck, Austria

Udo Müller

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Biocrates Life Sciences Ag. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Udo Müller. Retrieved from https://idiyas.com/inventor/udo-müller-a8pswszy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Udo Müller - Innovator in Ovarian Cancer Assessment

Introduction

Udo Müller is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of medical diagnostics, particularly in the assessment of ovarian cancer. His innovative work focuses on developing more sensitive biomarkers that can aid in the early detection of this disease.

Latest Patents

Udo Müller holds a patent for a "Metabolic biomarker set for assessing ovarian cancer." This invention relates to new biomarkers that enhance the sensitivity of ovarian cancer assessments, especially in the early stages of the disease. The patent also includes a method for evaluating ovarian cancer in patients and a kit designed for implementing this method.

Career Highlights

Udo Müller is associated with Biocrates Life Sciences AG, a company dedicated to advancing health through innovative biomarker research. His work at Biocrates has positioned him as a key player in the field of cancer diagnostics.

Collaborations

Udo Müller has collaborated with notable colleagues, including Simon Schafferer and Barbara Burwinkel. Their combined expertise contributes to the ongoing research and development of effective diagnostic tools.

Conclusion

Udo Müller’s contributions to ovarian cancer assessment through innovative biomarker research highlight the importance of early detection in improving patient outcomes. His work continues to pave the way for advancements in medical diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…